HORMONE REFRACTORY PROSTATE CANCER
Clinical trials for HORMONE REFRACTORY PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new HORMONE REFRACTORY PROSTATE CANCER trials appear
Sign up with your email to follow new studies for HORMONE REFRACTORY PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental pill SHY-ONC6 takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests an experimental oral drug called SHY-ONC6 in people with advanced or metastatic solid tumors (including breast, colon, lung, pancreatic, and others) that have stopped responding to standard treatments. The study aims to find a safe dose and check for …
Matched conditions: HORMONE REFRACTORY PROSTATE CANCER
Phase: PHASE1 • Sponsor: SHY Therapeutics • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for tough prostate cancer: first human trial of VIR-5500 begins
Disease control Recruiting nowThis early-stage study tests a new drug called VIR-5500 in people with advanced prostate cancer that has stopped responding to hormone treatment. The main goals are to check the drug's safety and find the right dose, while also seeing if it can shrink tumors or lower PSA levels. …
Matched conditions: HORMONE REFRACTORY PROSTATE CANCER
Phase: PHASE1 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC